Colorado Medical Board finds that so-called abortion reversal is outside “generally accepted standard of practice” - The Colorado Sun
Colorado Medical Board declares medication abortion reversal outside standard of practice, potentially affecting telehealth providers prescribing related medications.
Aforeworn detected this change in the Telehealth Cross-State Licensing space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Telehealth platforms and providers offering abortion-related services in Colorado, especially those prescribing mifepristone or misoprostol for reversal protocols. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately; board findings are effective upon publication.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telehealth Cross-State Licensing continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Colorado Medical Board now considers abortion reversal procedures not within generally accepted standard of practice, which may lead to disciplinary action for providers offering such services.
Who it affects
Telehealth platforms and providers offering abortion-related services in Colorado, especially those prescribing mifepristone or misoprostol for reversal protocols.
What you must do
Review and update clinical protocols to exclude abortion reversal treatments; ensure compliance with Colorado Medical Board standards.
Deadline
Immediately; board findings are effective upon publication.
Never miss a change like this again
Aforeworn watches Telehealth Cross-State Licensing around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Telehealth Cross-State Licensing
- DEA Proposes a Special Registry for Telehealth Providers of Controlled Substances - MedPage Today
- DEA Releases Long-Awaited Telehealth Special Registration Proposal, but Adoption Is Uncertain - McDermott+
- DEA Extends Telemedicine Flexibilities for Ketamine Prescribing: What Clinics Need to Know in 2026 - JD Supra
- Georgia medical board will limit virtual prescriptions - Atlanta Journal-Constitution
- DEA Proposed Telemedicine Prescribing Rule Could Burden Hospice Physicians and Hospice Operations - Morgan Lewis